Concerning the fact that Astatines enjoy anti-inflammatory effects, using the said medicine for the patients, suffering from chronic occlusive pulmonary disorders and other pulmonary complications, associated with inflammatory degeneration, has been studied.
According to a study, contracted earlier, the effect of Astatine on function of lungs of smokers was examined and respective results of the said study revealed that receiving the said group of medicines shall decrease emergency respiratory visitations, compared to other groups of medicines.
Considering another study, Astatines have protective effect on function of lungs of old people (discarding record of smoking by the said group). Moreover, considering the smokers, who gave up smoking after a long period or those who had recently started smoking and now, they gave up this habit, Astatine was prescribed for the aforesaid groups. Compared to the patients, who don’t receive Astatine, FEVI and FVC have decreased by 50% at least.
According to a recent study, contracted in Japan, Astatines slow down aggravation of chronic occlusive pulmonary diseases and enjoys noticeable advantages in decrease of mortality due to the said complications.